2018
DOI: 10.3390/app8050681
|View full text |Cite
|
Sign up to set email alerts
|

Experimental and Simulation Identification of Xanthohumol as an Inhibitor and Substrate of ABCB1

Abstract: Xanthohumol (XN) is a well-known prenylated flavonoid found in Humulus lupulus L. It is involved in several pharmacological activities, including the sensitization of doxorubicin-resistant breast cancer (MCF-7/ADR) cells to doxorubicin (DOX) through a reduction in cell viability and stemness. In the present study, we revealed another mechanism to further explain the reverse of the drug resistance of XN. In the MCF-7/ADR cell line, we found that XN inhibited the efflux functions of ATP-binding cassette subfamil… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 14 publications
1
4
0
Order By: Relevance
“…Some interactions of the lead compounds with Phe-343, Gln-347, Met-986 and Gln-990 have also been observed previously in structures solved with the transport substrates taxol [15] and vincristine [16]. Moreover, molecular docking simulations have previously indicated hydrophobic interaction between inhibitors and the ABCB1 residues Phe-303, Phe-343 and Ile-340, π-π stacking with Trp-232, Tyr-307 and Phe-303, and hydrogen bonding with Tyr-310, Gln-725, Glu-875, Tyr-953 and Gln-990 [15,20,40,52,[54][55][56]. Of these amino acids, only Trp-232, Tyr-310 and Tyr-953 are absent from interaction with any of our four lead compounds, although the interaction with Tyr-307 is predicted to be hydrophobic.…”
Section: Discussionsupporting
confidence: 70%
“…Some interactions of the lead compounds with Phe-343, Gln-347, Met-986 and Gln-990 have also been observed previously in structures solved with the transport substrates taxol [15] and vincristine [16]. Moreover, molecular docking simulations have previously indicated hydrophobic interaction between inhibitors and the ABCB1 residues Phe-303, Phe-343 and Ile-340, π-π stacking with Trp-232, Tyr-307 and Phe-303, and hydrogen bonding with Tyr-310, Gln-725, Glu-875, Tyr-953 and Gln-990 [15,20,40,52,[54][55][56]. Of these amino acids, only Trp-232, Tyr-310 and Tyr-953 are absent from interaction with any of our four lead compounds, although the interaction with Tyr-307 is predicted to be hydrophobic.…”
Section: Discussionsupporting
confidence: 70%
“…RESPA integrator was used to calculate the bonding interactions for a time step 2 fs (Stuart et al, 1996). All other parameters were associated in the settings followed as described elsewhere (Liu et al, 2018). After the final production run, the simulation trajectories of apo protein and complexed with ligands were analyzed for final outcome of RMSD and RMSF, ligand RMSF, derived from the simulation.…”
Section: Molecular Dynamics Simulation Study and Mm-gbsamentioning
confidence: 99%
“…In our previous screening work for ABCB1 inhibitors, we found that cardiotonic steroid compounds display anti-DOX resistance activity by stimulating ABCB1 ATPase activity [ 35 ]. Flavonoid compounds, e.g., xanthohumol and isoxanthohumol, also act as ABCB1 substrates and reverse MDR in MCF-7/ADR cells [ 36 , 37 ]. Other research groups also showed that tyrosine kinase inhibitors modulate ABCB1 functions through stimulating the ATPase activity [ 38 ].…”
Section: Resultsmentioning
confidence: 99%